NAD+ Precursor Chews vs. Fish Oil for Senior Dog Vitality: Which One Actually Moves the Needle

By Koranda Walsh, VMD, DACVIM (SAIM), DACVP (CP)

✓ Medically reviewed by Koranda Walsh, VMD, DACVIM (SAIM), DACVP (CP) — August 11, 2026 For general education — not a substitute for veterinary care.

Comparisons · August 17, 2026 · 6 min read

NAD+ precursor chews chase cellular energy; fish oil chases inflammation — senior dogs often need both, not either.

Before you add either one to the bowl, run this checklist:

• Ask what problem you’re actually treating. Sluggishness and stiffness after rest read the same to an owner but point to different biology — mitochondrial energy versus joint inflammation.
• Check the active, not the marketing name. “NAD+ precursor” almost always means nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) on the ingredient panel — if neither is named, you’re paying for a story.
• Check the fish oil source and form. Triglyceride-form EPA/DHA from a named fish species, not “marine lipid concentrate,” is what you want to see.
• Look for NASC on fish oil and multi-ingredient chews. It doesn’t prove the product works, but it’s the floor for manufacturing you can trust.
• Ask your vet to read the bloodwork before you read the label. A dog with elevated triglycerides needs a different fish oil conversation than a healthy senior on maintenance.
• Don’t expect either to feel like a light switch. Real change, when it happens, shows up over weeks, not days.

I’ve had this same conversation in the exam room more times this year than in the previous five combined. A client scrolls to a stop, turns her phone toward me mid-appointment, and asks whether the NAD+ chews her sister just started her own dog on are “better” than the fish oil her twelve-year-old beagle, Gus, has been on for three years. Gus weighs 24 pounds, has mild bilateral hip arthritis on radiographs, and his owner first noticed him hesitating at the bottom porch step last October — cold mornings, mostly, and always worse before his joint supplement kicked in for the day. She wasn’t looking to replace the fish oil. She wanted to know if she should stack something new on top of it because a video made cellular aging sound like the real problem underneath the stiffness. That’s the question underneath almost every version of this trend, and it deserves an actual answer instead of a shrug.

The two products are not competing for the same job

NAD+ precursor chews and fish oil aren’t really rivals — they’re aimed at different physiology, and treating them as interchangeable is where most of this trend goes sideways. Fish oil’s mechanism is well established: EPA and DHA compete with arachidonic acid in cell membranes and shift the body toward less inflammatory eicosanoids, which is why it shows up in joint, skin, and cardiovascular protocols. NAD+ precursors work upstream of that, feeding a coenzyme every cell needs for mitochondrial energy production and DNA repair, a pathway that measurably declines with age. NR and NMN are the two forms actually capable of raising NAD+ levels; the Niacin Fact Sheet for Health Professionals from the NIH Office of Dietary Supplements lays out how the body converts niacin and its related precursors into NAD+ through the same salvage pathway these chews are trying to boost.

What the dog data actually shows — and what it doesn’t yet

This is where I get strict, because “NAD+” has become a marketing word faster than it’s become a proven one in dogs. The strongest piece of canine evidence right now is a randomized, controlled trial published in Scientific Reports, which tested a combined senolytic and NAD+ precursor supplement in senior dogs and found improved owner-assessed cognitive function compared to placebo over the study period. That’s a real signal, and it’s the kind of result that should make you pay attention — but notice the specifics: it tested a combination product, it measured owner-reported cognition, not lab-confirmed cellular energy, and it hasn’t been replicated across independent labs yet. A single positive RCT is evidence, not proof, and I tell owners that distinction every time it comes up. Fish oil, by contrast, has decades of veterinary literature behind EPA/DHA for osteoarthritis, skin barrier function, and cognitive support in aging dogs — the Omega-3 Fatty Acids Fact Sheet for Health Professionals documents the broader physiological basis for those effects even though it’s written for human patients. If you want a category with a longer, deeper evidence trail, fish oil still wins that comparison.

Read the panel the way you’d read bloodwork

I tell every client the same thing about supplement labels that I tell them about a chemistry panel: the number means nothing until you know what it’s being measured against. A fish oil label listing “1,000mg fish oil” tells you almost nothing — what matters is the milligrams of EPA plus DHA specifically, because that’s the active fraction, and a cheap product can bury a low combined omega-3 count behind a big total-oil number. NAD+ chews deserve the same scrutiny. “NAD+ blend” on a front label with no milligram dose of NR or NMN listed on the supplement facts panel is the chew equivalent of an unflagged lab value — a number with no reference range attached is not useful information, and neither is an ingredient with no dose attached. If a brand won’t put a milligram figure on nicotinamide riboside or nicotinamide mononucleotide, or a combined EPA+DHA number in the guaranteed analysis, that’s the tell, not the claim on the front of the bag.

Where this actually lands for a dog like Gus

I’ve watched enough of these conversations resolve the same way that I’ve stopped hedging about it: for a dog with diagnosed joint disease, fish oil is not optional, and it’s not something an NAD+ chew replaces. The National Animal Supplement Council quality seal is a reasonable floor to require on both categories, since it audits manufacturing, labeling accuracy, and adverse-event reporting — though it says nothing about whether the product will actually work for your dog, which is a distinction owners conflate more often than they should. For a healthy senior whose owner is chasing general vitality rather than treating diagnosed inflammation, a properly dosed NAD+ precursor chew is a reasonable, evidence-informed add-on layered on top of fish oil, not instead of it, especially given how thin the independent replication still is outside that one Scientific Reports trial. Gus stayed on his fish oil. We added nothing else that month, because his triglycerides were already borderline and I wanted one clean variable before layering in a second supplement — that’s a bloodwork question, not a trend question, and it’s the kind of call that changes from one dog to the next depending on what the panel actually shows. If your dog’s energy has dropped since turning eight and you’re weighing this exact chew category on its own, our deeper look at NAD+ precursor chews for a senior dog whose energy dropped at 8 walks through the dosing questions in more depth. It’s also worth ruling out the mundane explanation first — our piece on whether cold weather makes a senior dog seem more stiff and slow than usual covers a confound that gets misread as “aging” constantly this time of year. And if cognition specifically is the worry driving the search, is MCT oil safe for senior dogs with cognitive decline is the adjacent comparison worth reading before you commit a supplement budget to any one lane.

Next year this category will look different — more brands will publish their own trial data rather than borrowing citations from human aging research, and the ones that don’t will get quieter about it. Until then, treat fish oil as the settled part of a senior dog’s routine and NAD+ precursors as the promising, still-young addition you layer on with your vet’s eyes on the bloodwork, not the algorithm’s.